Neurology Consultations™: Coordinating Care Between the Neurologist and Pharmacist in Multiple Sclerosis Treatment

Released On
October 23, 2019

Expires On
October 23, 2020

Media Type
Internet

Completion Time
75 minutes

Specialty
Neurology, Geriatric Medicine, Pharmacy, Primary Care

Topic(s)
Multiple Sclerosis

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians' Education Resource®, LLC.

 

Acknowledgement of Commercial Support

This activity is supported by an educational grants from Celgene Corporation and Sanofi Genzyme.

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)
  • Pharmacists — maximum of 1.25 APCE contact hours

All other health care professionals completing this course will be issued a statement of participation.

Program Overview

This activity features the Neurology Consultations™ platform, consisting of video clips featuring the latest clinical updates and case-based conversations between a neurologist and a pharmacist who specialize in the care of patients with multiple sclerosis (MS). This online educational activity features 3 patient case scenarios addressing topics such as family planning in the era of disease-modifying therapies (DMTs), magnetic resonance imaging (MRI) as a tool to inform clinical decisions, opportunities for patients who fail platform therapies, and other pertinent clinical issues in multiple sclerosis.

Benefits of Participating

  • Hear experts discuss real patient case scenarios
  • Learn something new and improve your clinical practice
  • Be inspired to converse with other specialists to improve care
  • Get answers to questions surrounding complicated clinical scenarios

Instructions for Participation and Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, educational content/video files will be available for your reference.
  • In order to receive a CME/CE certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This activity is intended for neurologists and pharmacists, as well as physician assistants, nurse practitioners, primary care physicians, and nurses, involved in the diagnosis, management, and treatment of MS.

Learning Objectives

  • Recognize the importance of early diagnosis and treatments of MS using efficacious DMT
  • Describe best practices for effective communication and coordination between specialty pharmacists and neurologists to optimize patient outcomes
  • Analyze data from recent clinical trials to determine the role of novel DMTs in the existing treatment landscape and the potential for improving clinical outcomes

Accreditation Statement/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.25 contact hours (0.125 CEUs) under the ACPE universal activity number 0290-9999-19-206-H01-P. The activity is available for CE credit through October 23, 2020.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours.

Faculty, Staff, and Planners’ Disclosures

Joseph R. Berger, MD

Professor of Neurology
Hospital of the University of Pennsylvania
Department of Neurology
Associate Chief of the Multiple Sclerosis Division
Perelman School of Medicine
Philadelphia, PA

Disclosures: Grant Research Support: Biogen, Genentech; Consultant: Biogen, Novartis, Sanofi/Genentech, Millennium/Takeda, Genzyme, Inhibikase, Excision BioTherapeutics, Celgene, Shire, Merck, Serono, Encycle, Finnstat, Amgen

Ryan Fuller, PharmD

Clinical Pharmacy Specialist
Department of Pharmacy
MS Division
Hospital of the University of Pennsylvania
Philadelphia, PA

Disclosures: Ryan Fuller, PharmD, has no relevant financial relationships with commercial interest to disclose

Pharmacy Times Continuing Education™
Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Olivia Mastrodonato; Susan Pordon, and Brianna Winters.

Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, PER® makes it a policy to ensure fair balance, independence, objectivity, and scientific rigor in all its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and a nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.